China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

Market Cap	46.53B -11.6%
Revenue (ttm)	31.60B +14.4%
Net Income	3.42B +1.6%
EPS	2.06 +2.0%
Shares Out	1.66B
PE Ratio	13.57
Forward PE	12.48
Dividend	1.04 (3.72%)
Ex-Dividend Date	Oct 17, 2025

Volume	12,691,300
Average Volume	14,079,101
Open	27.80
Previous Close	27.99
Day's Range	27.66 - 28.14
52-Week Range	27.65 - 35.36
Beta	0.21
RSI	35.38
Earnings Date	Mar 21, 2026

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, flu, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, anti-infection, and other treatment areas; Chi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 20,031
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2025, SHE:000999's revenue was 31.60 billion, an increase of 14.43% compared to the previous year's 27.62 billion. Earnings were 3.42 billion, an increase of 1.58%.